164 related articles for article (PubMed ID: 38486225)
1. Neighboring macrophage-induced alteration in the phenotype of colorectal cancer cells in the tumor budding area.
Kawamura I; Ohe R; Suzuki K; Kabasawa T; Kitaoka T; Takahara D; Kono M; Uchiyama N; Musha H; Futakuchi M; Motoi F
Cancer Cell Int; 2024 Mar; 24(1):107. PubMed ID: 38486225
[TBL] [Abstract][Full Text] [Related]
2. CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling.
Zhong Q; Fang Y; Lai Q; Wang S; He C; Li A; Liu S; Yan Q
J Exp Clin Cancer Res; 2020 Jul; 39(1):132. PubMed ID: 32653013
[TBL] [Abstract][Full Text] [Related]
3. NLRP3 Inflammasome Activation in MΦs-CRC Crosstalk Promotes Colorectal Cancer Metastasis.
Zhang L; Wang Y; Liu X; Zhang Y
Ann Clin Lab Sci; 2022 Jul; 52(4):571-579. PubMed ID: 36197770
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological Mechanism of Pingxiao Formula against Colorectal Cancer.
Yu W; Lu C; Wang G; Liang Z; Jiang Z; Liu Y; Yan J
Evid Based Complement Alternat Med; 2022; 2022():7884740. PubMed ID: 36582768
[TBL] [Abstract][Full Text] [Related]
5. Effects of IL-10 and T
Pradel LP; Franke A; Ries CH
J Leukoc Biol; 2018 Mar; 103(3):545-558. PubMed ID: 29345363
[TBL] [Abstract][Full Text] [Related]
6. Macrophage-based delivery of interleukin-13 improves functional and histopathological outcomes following spinal cord injury.
Van Broeckhoven J; Erens C; Sommer D; Scheijen E; Sanchez S; Vidal PM; Dooley D; Van Breedam E; Quarta A; Ponsaerts P; Hendrix S; Lemmens S
J Neuroinflammation; 2022 Apr; 19(1):102. PubMed ID: 35488301
[TBL] [Abstract][Full Text] [Related]
7. Role of tumor-associated macrophages at the invasive front in human colorectal cancer progression.
Inagaki K; Kunisho S; Takigawa H; Yuge R; Oka S; Tanaka S; Shimamoto F; Chayama K; Kitadai Y
Cancer Sci; 2021 Jul; 112(7):2692-2704. PubMed ID: 33964093
[TBL] [Abstract][Full Text] [Related]
8. High density of CD68+ tumor-associated macrophages predicts a poor prognosis in gastric cancer mediated by IL-6 expression.
Su CY; Fu XL; Duan W; Yu PW; Zhao YL
Oncol Lett; 2018 May; 15(5):6217-6224. PubMed ID: 29616104
[TBL] [Abstract][Full Text] [Related]
9.
Refai A; Gritli S; Barbouche MR; Essafi M
Front Cell Infect Microbiol; 2018; 8():327. PubMed ID: 30283745
[TBL] [Abstract][Full Text] [Related]
10. M1 Macrophage-Derived Interleukin-6 Promotes the Osteogenic Differentiation of Ligamentum Flavum Cells.
Qu X; Xu G; Hou X; Chen G; Fan T; Yang X; Chen Z
Spine (Phila Pa 1976); 2022 Aug; 47(15):E527-E535. PubMed ID: 35044344
[TBL] [Abstract][Full Text] [Related]
11. Multiple myeloma cell-derived IL-32γ increases the immunosuppressive function of macrophages by promoting indoleamine 2,3-dioxygenase (IDO) expression.
Yan H; Dong M; Liu X; Shen Q; He D; Huang X; Zhang E; Lin X; Chen Q; Guo X; Chen J; Zheng G; Wang G; He J; Yi Q; Cai Z
Cancer Lett; 2019 Apr; 446():38-48. PubMed ID: 30660652
[TBL] [Abstract][Full Text] [Related]
12. Histological spatial analysis on the induction of PD-L1
Suzuki K; Ohe R; Kabasawa T; Kitaoka T; Kawai M; Motoi F; Futakuchi M
Breast Cancer; 2023 Nov; 30(6):1094-1104. PubMed ID: 37792212
[TBL] [Abstract][Full Text] [Related]
13. [Corrigendum] LYPD8 regulates the proliferation and migration of colorectal cancer cells through inhibiting the secretion of IL‑6 and TNF‑α.
Xu J; Qian J; Zhang W; Chen E; Zhang G; Cao G; Wang F; Shen X; Zhou W; Song Z
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33882644
[TBL] [Abstract][Full Text] [Related]
14. DC-SIGN induction in alveolar macrophages defines privileged target host cells for mycobacteria in patients with tuberculosis.
Tailleux L; Pham-Thi N; Bergeron-Lafaurie A; Herrmann JL; Charles P; Schwartz O; Scheinmann P; Lagrange PH; de Blic J; Tazi A; Gicquel B; Neyrolles O
PLoS Med; 2005 Dec; 2(12):e381. PubMed ID: 16279841
[TBL] [Abstract][Full Text] [Related]
15. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis.
Rokavec M; Öner MG; Li H; Jackstadt R; Jiang L; Lodygin D; Kaller M; Horst D; Ziegler PK; Schwitalla S; Slotta-Huspenina J; Bader FG; Greten FR; Hermeking H
J Clin Invest; 2014 Apr; 124(4):1853-67. PubMed ID: 24642471
[TBL] [Abstract][Full Text] [Related]
16. The role of tumor budding in colorectal adenocarcinoma: Possible involvement of the intestinal cancer stem cell marker Lgr5.
Sadek SA; A Rehim DM; Fatima S
Indian J Pathol Microbiol; 2020; 63(1):32-37. PubMed ID: 32031119
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-10 increases macrophage-mediated chemotherapy resistance via FABP5 signaling in multiple myeloma.
Zhang M; Chen J; Zhang H; Dong H; Yue Y; Wang S
Int Immunopharmacol; 2023 Nov; 124(Pt A):110859. PubMed ID: 37666065
[TBL] [Abstract][Full Text] [Related]
18. CCL2 promotes macrophages-associated chemoresistance via MCPIP1 dual catalytic activities in multiple myeloma.
Xu R; Li Y; Yan H; Zhang E; Huang X; Chen Q; Chen J; Qu J; Liu Y; He J; Yi Q; Cai Z
Cell Death Dis; 2019 Oct; 10(10):781. PubMed ID: 31611552
[TBL] [Abstract][Full Text] [Related]
19. Nuclear translocation of thioredoxin-1 promotes colorectal cancer development via modulation of the IL-6/STAT3 signaling axis through interaction with STAT3.
Wu A; Fang D; Liu Y; Shi X; Zhong Z; Zhou B; Ye L; Sun X; Jiang L
Theranostics; 2023; 13(14):4730-4744. PubMed ID: 37771783
[No Abstract] [Full Text] [Related]
20. PRRX1 promotes colorectal cancer stemness and chemoresistance via the JAK2/STAT3 axis by targeting IL-6.
Zhong L; Tan W; Yang Q; Zou Z; Zhou R; Huang Y; Qiu Z; Zheng K; Huang Z
J Gastrointest Oncol; 2022 Dec; 13(6):2989-3008. PubMed ID: 36636075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
